http://www.syntheticbiologics.com/ http://www.syntheticbiologics.com/2013-05-15-Synthetic-Biologics-Reports-First-Quarter-2013-Financial-Results Wed, 15 May 2013 07:00:00 -0400 http://www.syntheticbiologics.com/2013-05-15-Synthetic-Biologics-Reports-First-Quarter-2013-Financial-Results http://www.syntheticbiologics.com/2013-04-19-Synthetic-Biologics-Reiterates-that-the-Infectious-Disease-Collaboration-with-Intrexon-Remains-in-Effect Fri, 19 Apr 2013 19:00:00 -0400 http://www.syntheticbiologics.com/2013-04-19-Synthetic-Biologics-Reiterates-that-the-Infectious-Disease-Collaboration-with-Intrexon-Remains-in-Effect http://www.syntheticbiologics.com/2013-04-16-Synthetic-Biologics-Reports-Year-End-2012-Financial-Results -- Strengthening Infectious Disease Portfolio to Include C. difficile, Pertussis and Acinetobacter Targets -- Tue, 16 Apr 2013 07:00:00 -0400 http://www.syntheticbiologics.com/2013-04-16-Synthetic-Biologics-Reports-Year-End-2012-Financial-Results http://www.syntheticbiologics.com/2013-04-04-Synthetic-Biologics-Announces-Issuance-of-U-S-Patent-Covering-Combination-of-Estriol-and-Copaxone-for-Multiple-Sclerosis -- Patent Expands Company's Patent Portfolio to Include Combination with Number One Selling Multiple Sclerosis Drug -- Thu, 04 Apr 2013 13:30:00 -0400 http://www.syntheticbiologics.com/2013-04-04-Synthetic-Biologics-Announces-Issuance-of-U-S-Patent-Covering-Combination-of-Estriol-and-Copaxone-for-Multiple-Sclerosis http://www.syntheticbiologics.com/2013-03-12-Synthetic-Biologics-to-Present-at-the-25th-Annual-ROTH-Conference Tue, 12 Mar 2013 07:00:00 -0400 http://www.syntheticbiologics.com/2013-03-12-Synthetic-Biologics-to-Present-at-the-25th-Annual-ROTH-Conference